José María Gutiérrez spends much of his time researching Venom, Snake venom, Antivenom, Biochemistry and Bothrops asper. His work carried out in the field of Venom brings together such families of science as Zoology, Immunology and Pharmacology. His research in Snake venom is mostly concerned with Myotoxin.
His studies in Myotoxin integrate themes in fields like Myocyte, Molecular biology, Bothrops moojeni and Skeletal muscle. His research integrates issues of Snake bites, Toxicology, Neutralization and Ophidia in his study of Antivenom. His Bothrops asper study contributes to a more complete understanding of Bothrops.
The scientist’s investigation covers issues in Venom, Snake venom, Antivenom, Immunology and Pharmacology. Venom connects with themes related to Neutralization in his study. Snake venom is a subfield of Biochemistry that José María Gutiérrez tackles.
His Antivenom research focuses on Zoology and how it connects with Ecology and Viperidae. His Immunology research includes elements of Potency and Microbiology. The Pharmacology study combines topics in areas such as Batimastat and Median lethal dose.
His main research concerns Venom, Antivenom, Snake venom, Pharmacology and Envenomation. His Venom research incorporates elements of Zoology, Phospholipase A2 and Toxicity. His Antivenom research is multidisciplinary, incorporating elements of Toxin, Antibody, Neutralization, Immunology and Bothrops.
His Bothrops research is multidisciplinary, incorporating perspectives in Traditional medicine and Micrurus. The study incorporates disciplines such as Molecular biology, Type IV collagen and Matrix metalloproteinase, Metalloproteinase in addition to Snake venom. His Pharmacology study combines topics in areas such as Necrosis, In vitro, Snake antivenom and In vivo.
José María Gutiérrez focuses on Antivenom, Venom, Snake venom, Pharmacology and Zoology. The various areas that José María Gutiérrez examines in his Antivenom study include Virology, Antibody, Immunization, Therapeutic antibody and Elapidae. His research in Venom intersects with topics in Neutralization and Immunology.
His study in Snake venom focuses on Myotoxin in particular. His study explores the link between Pharmacology and topics such as Toxicity that cross with problems in Severe complication, Bothrops asper, Morphine and Clinical efficacy. His Envenomation study incorporates themes from Toxicology and Polylepis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Phospholipase A2 myotoxins from Bothrops snake venoms
José María Gutiérrez;Bruno Lomonte.
Toxicon (1995)
Snake venom metalloproteinases:Their role in the pathogenesis of local tissue damage
José María Gutiérrez;Alexandra Rucavado.
Biochimie (2000)
Confronting the Neglected Problem of Snake Bite Envenoming: The Need for a Global Partnership
José María Gutiérrez;R. David G Theakston;David A Warrell.
PLOS Medicine (2006)
Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity
José Marı́a Gutiérrez;Charlotte L Ownby.
Toxicon (2003)
Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage.
José María Gutiérrez;Alexandra Rucavado;Teresa Escalante;Cecilia Díaz.
Toxicon (2005)
Venoms, venomics, antivenomics
Juan J. Calvete;Libia Sanz;Yamileth Angulo;Bruno Lomonte.
FEBS Letters (2009)
The Global Snake Bite Initiative: an antidote for snake bite.
David J. Williams;José María Gutiérrez;Robert A. Harrison;David A. Warrell;David A. Warrell.
The Lancet (2010)
Snakebite envenoming from a global perspective: Towards an integrated approach.
José María Gutiérrez;David J. Williams;Hui Wen Fan;David A. Warrell;David A. Warrell.
Toxicon (2010)
An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica.
JoséMaría Gutiérrez;Claudio Avila;Ermila Rojas;Luis Cerdas.
Toxicon (1988)
Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom
JoséMaría Gutiérrez;JoséA. Gené;Gustavo Rojas;Luis Cerdas.
Toxicon (1985)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Costa Rica
Spanish National Research Council
University of Costa Rica
Spanish National Research Council
University of Virginia
University of Oxford
Karolinska Institute
University of Costa Rica
University of Padua
Universidade de São Paulo
University of British Columbia
University of Pittsburgh
Grenoble Alpes University
University of California, Berkeley
Centre national de la recherche scientifique, CNRS
Vanda Pharmaceuticals (United States)
The University of Texas Southwestern Medical Center
Leiden University
University of Nebraska Medical Center
University of Siena
The Ohio State University
University of Adelaide
University of Queensland
University of Rochester Medical Center
The Royal Free Hospital
Erasmus University Rotterdam